Process for detecting PrP using a macrocyclic adjuvant ligand
US7217530B2 · kind B2 · utility
1Cited by
2References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 9, 2005 |
| Grant date | May 15, 2007 |
| Priority date | — |
| Expiry date | Jun 9, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/807
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A process for detecting the forms of the prion pathogens responsible for subacute, transmissible, spongiform encephalopathies, including a macrocyclic adjuvant ligand (AML), free or bound to a support, that is added to a biological sample capable of containing PrPsc, the resulting suspension then being reacted with an anti-PrPsc antibody, and the presence of PrP is then detected.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.